Ms. Diltz is a Protocol Monitor at the DCC and has over 30 years of experience managing clinical trials and monitoring for regulatory compliance. Ms. Diltz is ACRP-certified as a Clinical Research Coordinator (CCRC). Ms. Diltz was the primary monitor for the NN104 RHAPSODY study, and will be the primary monitor for the NN109 MAGINE study.